CLSI M39 A3 : 3ED 2009

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Information System Design
6 Data Analysis
7 Data Presentation
8 Use of Cumulative Antimicrobial Susceptibility Reports
9 Limitations of Data, Data Analysis and Data Presentation
10 Statistical Considerations
References
Additional References
Appendix A - Suggestions for Verification of Antimicrobial
             Susceptibility Test Results and Confirmation
             of Organism Identification
Appendix B - Rationale Behind the 'First Isolate per Patient'
             Analysis Recommendation
Appendix C - Example of Supplemental Analyses - Stratifying
             Cumulative Antibiogram Data by Various Parameters
Appendix E1 - Cumulative Antimicrobial Susceptibility Report
              Example - Antimicrobial Agents Listed
              Alphabetically (Hypothetical Data
Appendix E2 - Cumulative Antimicrobial Susceptibility Report
              Example - Antimicrobial Agents Listed by Class
              (Hypothetical Data)
Appendix F - Example of Graph to Illustrated Trend in
             Susceptibility Over Five Years
Appendix G - Steps for Presenting Local Cumulative Antibiogram
             Report to Health Care Professionals
Appendix H - Statistical Methods for Examining Percent
             Susceptible
Appendix I - Glossary I (Part 1) - Beta-lactams: Class and
             Subclass Designation and Generic Name
Glossary I (Part 2) - Non-Beta-lactams: Class and Subclass
                      Designation and Generic Name
Glossary II - Abbreviations/Routes of Administration/Drug
              Class for Antimicrobial Agents
Summary of Delegate Comments and Subcommittee Responses
The Quality Management System Approach
Related CLSI Reference Materials